Weekly Spotlight - 07.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Chromosomal Telomere Shortening Linked to Cardiomyopathy in FA Patients

Telomere shortening in Friedreich's ataxia (FA) patients is linked to cardiomyopathy, a serious heart condition. The study suggests telomere length as a potential biomarker for FA progression. Notably, FA patients experience faster telomere decline, particularly after age 35, offering valuable insights into disease dynamics.

Wearable Sensors Revolutionise Friedreich's Ataxia Assessment and Care

Wearable devices present a novel approach to assessing Friedreich's ataxia severity, surpassing traditional in-clinic assessments. By delivering continuous and objective data on daily activities, these devices enhance understanding of disease progression. The integration of machine learning models further boosts predictive accuracy, holding potential to transform patient care.

Friedreich Ataxia: Uniparental IsoDisomy Discovery in Genetic Diagnosis

This article covers a rare case of Friedreich's ataxia caused by uniparental isodisomy, wherein a child inherited two identical copies of a chromosome segment from one parent. This discovery adds complexity to FA diagnosis and highlights the need for comprehensive diagnostic approaches to achieve accurate diagnoses.

Cerebellar Stimulation: A New Hope for Ataxia Patients

Dr. Gilles Naeije's study examines cerebellar transcranial direct current stimulation (ctDCS) as a potential therapy to alleviate ataxic symptoms in FA patients. Longer ctDCS sessions impact both symptoms and brain activity, assessed through sophisticated speech and balance evaluations. Initial results show promise, though responses vary individually.